|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 36/185 | |
| A61K 31/352 | |||
| A61K 31/35 | |||
| A61K 31/05 | |||
| A61K 45/06 | |||
| A61P 25/18 | |||
| A61P 25/22 |
| (11) | Patento numeris | 2249848 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08869534.1 |
| Europos patento paraiškos padavimo data | 2008-12-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-11-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-05-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2008/004217 |
| Data | 2008-12-17 |
| (87) | Numeris | WO 2009/087351 |
| Data | 2009-07-16 |
| (30) | Numeris | Data | Šalis |
| 0800390 | 2008-01-04 | GB |
| (72) |
KIKUCHI, Tetsuro, JP
MAEDA, Kenji, JP
GUY, Geoffrey, GB
ROBSON, Philip, GB
STOTT, Colin, GB
|
| (73) |
GW Pharma Limited,
Sovereign House, Histon Cambridge CB24 9BZ,
GB
Otsuka Pharmaceutical Co., Limited, 9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535, JP |
| (54) | USE OF CANNABINOIDS IN COMBINATION WITH ARIPIPRAZOLE |
| USE OF CANNABINOIDS IN COMBINATION WITH ARIPIPRAZOLE |